The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007.
Michaela Ann Dinan
No relevant relationships to disclose
Xiaojuan Mi
No relevant relationships to disclose
Shelby D. Reed
No relevant relationships to disclose
Bradford Richard Hirsch
No relevant relationships to disclose
Gary H. Lyman
Research Funding - Genomic Health
Lesley H Curtis
No relevant relationships to disclose